PARTNERING

Dr. Ansel specializes in Interventional Cardiology and Cardiology in Columbus, Ohio, where he is a Practicing Partner of MidOhio Cardiology and Vascular Consultants Inc. He serves as Clinical Director of Peripheral-Vascular Interventionists in the Division of Cardiology of Riverside Methodist Hospital, and as Director of the Center for Critical Limb Care at Riverside Methodist Hospital, Columbus, Ohio. Dr. Ansel is an Assistant Clinical Professor of Medicine in the Department of Internal Medicine of the Medical University of Ohio in Toledo Medical Center and Associate Director of Ohio Health Research Institute.

Dr. Ansel is a Founding Board Member of the VIVA Conference. He also serves on the Peripheral Vascular Committee for the American College of Cardiology.

Dr. Azzalini is the Director of Interventional Cardiology Research and an Associate Professor of Medicine at the Heart Institute at the University of Washington Medical Center. His background includes medical training across four countries and two continents. Dr. Azzalini provides unique approaches to treating complex heart conditions, including PCI, CTO and CHIP populations. His clinical research includes co-authoring 196 peer-reviewed articles, and he has participated in four clinical trials over the past 15 years.

Dr Michael Lichtenberg is the Chief Medical Officer of the Angiology Department at Vascular Centre Clinic Arnsberg, Germany. He is an interventional cardiologist and angiologist with more than 15 years of experience in the field of endovascular interventions. While he values his day-to-day experiences in interventional care, his main interest is the evaluation of new devices, techniques and procedures for intervention of peripheral artery disease. Dr Lichtenberg has performed a series of studies in this area and conducted many clinical trials. He presents his research at conferences around the world. In 2011, Dr Lichtenberg was awarded the Fellowship of the European Board of Cardiology. In 2017 he was elected for the executive secretary of the Germany Angiology Society (DGA).Since January 2020 he is the President of the German Angiology Society.

Dr. Lombardi is a board-certified cardiologist at the University of Washington Medical Center and Northwest Hospital; Clinical Professor of Medicine, Division of Cardiology; and the Director of Complex Coronary Artery Disease Therapies at the University of Washington Medical Center in Seattle. He is a well-known expert in complex coronary intervention and complete chronic total occlusion therapies.

Dr. Sean Lyden is a board-certified vascular surgeon who performs more than 200 procedures each year. His clinical interests include failed endovascular aneurysm repair, drug-coated balloon use in arterial disease, and popliteal artery entrapment syndrome. He is Chairman of Vascular Surgery at Cleveland Clinic and leads a team of over 30 physicians across Ohio and Florida.

Dr. Lyden graduated with a bachelor’s degree from the University of Notre Dame and earned his medical degree at the University of Cincinnati College of Medicine in Ohio. He completed a general surgery residency and trauma research fellowship at The University of Tennessee Health Sciences Center in Memphis, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his training with a vascular surgery fellowship at the University of Rochester in New York and joined the staff at Cleveland Clinic in 2001.

An active researcher, Dr. Lyden is involved in clinical trials studying various topics including thoracic and abdominal stent grafting; lower extremity interventional therapies with drug-coated balloons; drug-eluting stents and percutaneous femoral popliteal bypass; carotid stenting, and deep venous thrombosis treatments. He has delivered more than 400 presentations at national and international medical conferences and symposia.

Dr. Lyden has authored or co-authored more than 160 articles in leading publications, including the Journal of Vascular Surgery, New England Journal of Medicine, and Circulation. He has also written chapters in several vascular textbooks. He serves on the editorial board of Endovascular Today and is a reviewer for multiple vascular journals.

A distinguished Fellow of the Society for Vascular Surgery and a Fellow of the American College of Surgeons, Dr. Lyden is a member of the Board of Directors of The VIVA Foundation and consults on many industry medical advisory boards. In addition, he serves as Chief Medical Officer of Excelerate Strategic Health Sourcing, a venture between Cleveland Clinic and Vizient to save health care organizations money with provider-led, physician-engaged sourcing.

Dr. Mathews is an interventional cardiologist and endovascular specialist at Bradenton Cardiology Center in Bradenton, FL specializing in complex coronary interventions, structural heart procedures, endovascular therapies, and novel device research. He did his undergraduate training at Rensselaer Polytechnic Institute in Troy, NY receiving a degree in Biology and Electronic Media Arts & Communication and subsequently working in the multimedia technology sector. He later went on to graduate and professional training at Tufts University in Boston, MA where he received his MD and Master’s in Health Communication at the Sackler School of Biomedical Sciences focusing on telemedicine and interactive education. He completed residency training and fellowship training in Cardiovascular Disease, Advanced Cardiac Imaging, and Interventional Cardiology at the Washington University School of Medicine in St. Louis, MO. He is currently in an investigator in several trials and is actively involved in endovascular research.

Dr. Mustapha is an Interventional Cardiologist specializing in endovascular revascularization of peripheral artery disease (PAD), specifically critical limb ischemia, or CLI. He is an internationally recognized leader in the field and a co-founder of the first Advanced Cardiac & Vascular Amputation Prevention Centers Michigan State University College of Osteopathic Medicine Grand Rapids, Michigan. In addition to his practice, Dr. Mustapha serves on the editorial boards of several scientific publications. He has also authored or co-authored numerous articles and abstracts and is highly sought-after as a teacher and trainer for physicians throughout the world.

Dr. Mustapha is Clinical Associate Professor of Medicine at Michigan State University of Osteophathic Medicine. He is the Founder and Director of the AMPutation Prevention Symposium, and a Founding Board Member of the CLI Global Society.

Dr. Razavi specializes in image-guided therapy for cancer and endovascular treatment of vascular diseases. He serves as the Editor-in-Chief for Techniques in Vascular & Interventional Radiology and is a member of Council on Cardiovascular Radiology and Intervention, American Heart Association. He is a member of the Editorial Board of the Journal of Endovascular Specialists and is a reviewer for several other journals. Dr. Razavi co-founded Boston Scientific Santa Rosa Corp. in 1998.

Dr. Razavi chairs the Scientific Program for the Society of Interventional Radiology. He has held faculty positions at UCLA and Stanford University, and was the Director of Special Procedures at the West Los Angeles VA Medical Center. He serves on various committees of national organizations such as the Food & Drug Administration/SIR Device Forum. His scientific work is featured in national and international media programs, and he has authored or co-authored numerous scientific publications, abstracts and book chapters.

Prof. Scheinert is the Medical Director at University Hospital Leipzig and Head of the Center for Vascular Medicine, Angiology and Vascular Surgery. He is recognized internationally for his expertise in both coronary and peripheral vascular interventions. Prof. Scheinert’s special interest areas are treatment of critical limb ischemia, endovascular repair of aneurysms and dissections of the thoracic and abdominal aorta. He has written numerous articles and abstracts, and is actively involved in clinical research to evaluate new technologies. Prof. Scheinert is the Director of LINC (Leipzig Interventional Course) and is also a Board Member of Euro PCR.

Dr. Schmidt serves as Deputy Director at University Hospital, in Leipzig Germany, where he is also Senior Interventionalist in the Division of Interventional Angiology. He previously held the position of Chief Senior Physician in the Department of Angiology, Park Hospital in Leipzig, Germany. He has published more than 75 research papers.